Researchers of Israel's Weizmann Institute of Science have achieved a significant new development which may have far reaching implications for the treatment of autoimmune diseases which attack the body's own tissue by mistake. The scientists have managed to convince the immune systems of mice to instead attack an enzyme significant to the body's autoimmune process known as matrix metallopeptidase 9 (MMP9).